We sincerely invite you to join us in the SunWay Biotech Presentation of BIO Asia-Taiwan. Please register for Free Admission to On-demand Company Presentations of BIO Asia-Taiwan during July 21-25. After registration, please click Session and then type cp31 or SunWay to join our Company Presentation and know more about our service. Register Now: https://bit.ly/3xFl57D  

In a highly influential SNQ National Quality Mark evaluation, SunWay Biotech’s flagship product, ANKASCIN® 568-R red yeast extract, has emerged as the sole recipient of the Bronze Award in the Nutrition and Special Functional Health Ingredients category. This prestigious accolade, which also places ANKASCIN® 568-R as the top-ranking product in the entire category, was received by President John Pan on behalf of SunWay Biotech. It signifies the government, industry, and academia’s recognition of the company’s outstanding innovation and product quality in the field of health foods. ANKASCIN® 568-R is a groundbreaking red yeast supplement material known for its unique red yeast extract that does not contain Monacolin K. It boasts a rich content of Monascin and Ankaflavin, both of which have been scientifically proven to offer significant health benefits, including anti-glycation, antioxidant, and anti-inflammatory properties. Furthermore, ANKASCIN® 568-R has successfully passed rigorous scientific research and clinical trials, earning certification from the United States FDA as a New Dietary Ingredient (NDI). This achievement further substantiates its safety and efficacy as a leading health ingredient. The SNQ National Quality Mark is a highly authoritative award that symbolizes “Safety and Quality,” aiming to recognize exceptional achievements in products that promote healthy and high-quality living. This evaluation brought together a panel of 160 experts from the industry, government, and academia, who selected 16 outstanding […]

  California, USA – March 14, 2024 – SunWay Biotech and Gnosis by Lesaffre proudly announce their strategic partnership at the Natural Products Expo West. Following the alliance ceremony, the companies unveiled their inaugural product, MenaQ7® Metabolic, featuring the ANKASCIN® 568-R ingredient and aiming at the USD 2 Billion Global vitamin K2 market. This product symbolizes their joint effort and marks the beginning of deeper collaboration in product development and international supply chain integration. Gnosis, a subsidiary of Lesaffre with 170 years of expertise, focuses on fermentation solutions for nutrition, health, and personal care businesses. A key global player in fermentation for more than a century, Lesaffre, with a €2.7 billion turnover, and established on all continents, counts 11,000 employees. Julie Lemahieu, Markets and Solutions Director, highlighted Gnosis’s global presence ensures close collaboration with clients worldwide. MenaQ7® Metabolic combines two key active ingredients, MenaQ7® Vitamin K2 as MK-7 and ANKASCIN® 568-R. MenaQ7® is the only Vitamin K2 as MK-7 clinically proven beneficial for bone and heart health, offering the highest quality assurance. ANKASCIN® 568-R is the world’s only red yeast rice fermentation material without Monacolin K (Statin). SunWay Biotech, invited by the US Pharmacopeial Convention (USP), contributed to the development of a red yeast rice health product chapter, and ANKASCIN® 568-R has obtained New Dietary Ingredient (NDI) status. With over […]